Report overview
The hepatitis b vaccine is a vaccine against hepatitis b.That is, from hepatitis b virus carrier plasma isolation of hepatitis b surface antigen (HbsAg), after treatment and made.After second liver vaccine is inoculated, can stimulate immune system to produce protective antibody, this kind of antibody is in the humoral in the person, once second liver virus appears, antibody can act immediately, clear its, prevent infection, won't harm liver, make human body had the immunity that prevents second liver thereby.Therefore, hepatitis b vaccine has become an indispensable umbrella in life.Prevention generally lasts for at least 12 years, so there is no need for anti-hbs surveillance or enhanced immunity in the general population.However, anti-hbs surveillance can be carried out on high-risk groups, such as anti-hbs <10mIU/ml, which can be given enhanced immunity.
This report aims to provide a comprehensive presentation of the global market for Recombinant Hepatitis B Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Hepatitis B Vaccine. This report contains market size and forecasts of Recombinant Hepatitis B Vaccine in global, including the following market information:
Global Recombinant Hepatitis B Vaccine Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Recombinant Hepatitis B Vaccine Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Recombinant Hepatitis B Vaccine companies in 2022 (%)
The global Recombinant Hepatitis B Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
10mcg/ml Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Recombinant Hepatitis B Vaccine include Merck, GlaxoSmithKline Plc, Pfizer Inc., Sanofi Pasteur, CSL Limited, Emergent Biosolutions, Serum Institute of India, Johnson & Johnson and Hualan Biological Engineering, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Recombinant Hepatitis B Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Hepatitis B Vaccine Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Recombinant Hepatitis B Vaccine Market Segment Percentages, by Type, 2022 (%)
10mcg/ml
10mcg/0.5ml
Global Recombinant Hepatitis B Vaccine Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Recombinant Hepatitis B Vaccine Market Segment Percentages, by Application, 2022 (%)
Newborn
Primary School Students
Adult
Global Recombinant Hepatitis B Vaccine Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Recombinant Hepatitis B Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Hepatitis B Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Recombinant Hepatitis B Vaccine revenues share in global market, 2022 (%)
Key companies Recombinant Hepatitis B Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Recombinant Hepatitis B Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
GlaxoSmithKline Plc
Pfizer Inc.
Sanofi Pasteur
CSL Limited
Emergent Biosolutions
Serum Institute of India
Johnson & Johnson
Hualan Biological Engineering
NCPC
China National Biotec Group
Dalian Hissen Bio-pharm
Beijing Tiantan Biological
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Hepatitis B Vaccine, market overview.
Chapter 2: Global Recombinant Hepatitis B Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Recombinant Hepatitis B Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Hepatitis B Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Recombinant Hepatitis B Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
